Login
$KRYS
$297.90 -$7.33 (2.4%) Live

Company Executives

Officer Age In this role Joined 2025 pay Source
Krish S. Krishnan Also a director
Chairman, President, and Chief Executive Officer
61 Not stated Not stated $10,442,485
Kathryn A. Romano
Chief Accounting Officer
Title from the Form 4 dated Feb 27, 2026
45 Since 2020
6 years
Not stated $2,258,697
John C. Thomas
EVP, General Counsel
Title from the Form 4 dated Jun 25, 2026
52 Since 2026
this year
2021 Not reported
Suma M. Krishnan Also a director
Founder and President, R&D
61 Not stated Not stated $6,948,401
Laurent Goux
EVP, Head of International
Title from the Form 3 dated Mar 1, 2026
51 Since 2026
this year
2021 Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
8
serving now
Independent
6 of 6
stated in the proxy; 2 not stated
Average tenure
6.9 years
from year joined
CEO also chairs the board
Yes
Krish S. Krishnan
Director Age On board Independent Committees Other public boards 2025 pay Source
Krish S. Krishnan
61 2016
10 years
Not stated
Commercial Advisory Committee · Chair
None stated Paid as CEO
Daniel S. Janney
60 2016
10 years
Independent
Compensation Committee · Chair
None stated $526,472
Suma M. Krishnan
61 Not stated Not stated None stated None stated Not stated
Christopher Mason
68 2021
5 years
Independent
Science and Technology Committee · Chair
None stated $468,972
Julian S. Gangolli
68 2019
7 years
Independent
Nominating and Corporate Governance Committee · Chair Compensation Committee Audit Committee
Outlook Therapeutics, Inc. $491,472
Catherine Mazzacco
61 2023
3 years
Independent
Nominating and Corporate Governance Committee Commercial Advisory Committee
Sight Sciences, Inc. $470,972
Dino A. Rossi
71 2017
9 years
Independent
Audit Committee · Chair Compensation Committee
None stated $491,972
E. Rand Sutherland
56 2022
4 years
Independent
Audit Committee Commercial Advisory Committee
Upstream Bio, Inc. $476,472

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 3, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support